EGFR and acute myeloid leukemia: The significant activation of oncogenic pathways such as MAPK, Rap1, and ErbB signaling in AML-associated eccDNAs mirrored findings in solid tumors, where these pathways were frequently co-opted for proliferation and survival (17).